Correction to: BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis

Neurotherapeutics. 2023 Apr;20(3):909. doi: 10.1007/s13311-023-01381-5.

Manal T Usmani¹, Robert P Krattli Jr¹, Sanad M El-Khatib¹, Anh C D Le¹, Sarah M Smith², Janet E Baulch², Ding Quan Ng^{3

4}, Munjal M Acharya^{5

6}, Alexandre Chan^{7

8}

¹ Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, CA, USA.
² Department of Radiation Oncology, School of Medicine, University of California, Irvine, CA, USA.
³ Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA, USA.
⁴ Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, USA.
⁵ Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, CA, USA. [email protected].
⁶ Department of Radiation Oncology, School of Medicine, University of California, Irvine, CA, USA. [email protected].
⁷ Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA, USA. [email protected].
⁸ Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, USA. [email protected].

No abstract available

Publication types